Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephen Liu
Georgetown University Hospital Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peter Maccullum
Melbourne, Victoria, Australia
- University of Southern California-Norris
Los Angeles, California, United States
- St. Joseph Heritage Healthcare
Santa Rosa, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Walter Reed National Military Medical Center
Bethesda, Maryland, United States
- University of North Carolina Lineberger Cancer Center
Chapel Hill, North Carolina, United States
- University of Pennsylvania-Abramson Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt-Ingram Cancer Center (vicc)
Nashville, Tennessee, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Swedish Cancer Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2015
- Primary completion
- 31 Jan 2017
- Completion
- 31 Jan 2017
- Last update posted
- 12 Jan 2023
- Registered enrollment
- 21
- Registry id
- NCT02454842
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.